Potentiation of the extracellular release of equine neutrophil elastase and alpha-1-proteinase inhibitor by a combination of two bacterial cell wall components: fMLP and LPS.

Summary

# Editorial Summary Endotoxaemia—a common complication in equine colic and sepsis—involves the release of bacterial cell wall components into the bloodstream that trigger excessive neutrophil activation. Dagleish and colleagues investigated how two key bacterial components, lipopolysaccharide (LPS) and fMLP-like peptides, work together to stimulate equine neutrophils in vitro, examining the release of neutrophil elastase and alpha-1-proteinase inhibitor (α1-PI). Their findings demonstrated that whilst fMLP alone produced minimal neutrophil activation, LPS priming significantly potentiated the neutrophil response to fMLP, resulting in substantially increased extracellular release of both elastase and α1-PI. These results are particularly relevant to practitioners managing endotoxic cases, as uncontrolled neutrophil elastase release—especially when α1-PI cannot adequately inhibit it—contributes to the tissue damage and systemic inflammation characteristic of severe endotoxaemia; understanding this two-stage activation mechanism may inform therapeutic strategies aimed at modulating neutrophil responses during critical illness.

Read the full abstract on PubMed

Key Findings

• •Equine neutrophils require priming with LPS to generate reactive oxygen intermediates in response to fMLP
• •LPS and fMLP-like peptides are Gram-negative bacterial cell wall components released during endotoxaemia
• •Combined exposure to LPS and fMLP potentiates extracellular release of neutrophil elastase and alpha-1-proteinase inhibitor

Conditions Studied